Judge orders Timothy Busfield’s release from jail pending child sex abuse charges
Judge finds evidence against Busfield to be ‘neutral’Busfield professes innocence, calls allegations ‘lies’Preliminary hearing in case set for…
Can you really price global regime change?
ORLANDO, Florida, Jan 20 (Reuters) – U.S. President Donald Trump’s latest foreign policy and trade war salvos are…
Space sector eyes further investment growth in 2026 after record year
Investment in space tech driven by defense-linked systemsU.S. leads with $7.3 billion in space funding, driven by defense…
Weaker UK jobs data may offer inflation relief to BoE
Private sector pay grows by least since November 2020UK regular wage growth slows to 4.5%Jobless rate holds at…
Israel government sends 2026 budget to parliament, approval at risk from rifts
JERUSALEM, Jan 19 (Reuters) – Israel’s Finance Ministry said on Monday it delivered the 2026 state budget draft…
Renewables push China’s fossil‑fuelled power into first annual drop in 10 years
BEIJING, Jan 19 (Reuters) – China’s mostly coal-based thermal power generation fell in 2025 for the first time…
Australia parliament returns with moment of silence for Bondi mass shooting victims
Item 1 of 2 A general view of Australia’s federal parliament, known as Parliament House, ahead of the…
Trump wants nations to pay $1 billion to stay on his peace board, report says
Jan 17 (Reuters) – The Trump administration wants nations to pay $1 billion to stay on his peace…
Iran’s leader Khamenei accuses Trump of inciting deadly protests
US-based rights group says 3,090 people have been killedInternet blackout reimposed after brief easing of restrictions, monitor saysIran…
Argentina growth outlook stable, but much depends on potential debt comeback
BUENOS AIRES, Jan 16 (Reuters) – Argentina’s economy is set to grow at a slightly slower pace this…
Trump housing plan to allow 401(k) money for down payments, adviser says
WASHINGTON, Jan 16 (Reuters) – The Trump administration plans to allow investors to use some of their retirement…
Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalledTzield pushed back after adverse event…